Koen Wuyts

Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121)

Jean‐François Bonfanti, Christophe Meyer, Frédéric Doublet et al. · Journal of Medicinal Chemistry · 2008 · 100 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate, Part 1:  Improving the Pharmacokinetic Profile Using the Structure−Property Relationship

Jean‐François Bonfanti, Frédéric Doublet, Jérôme Fortin et al. · Journal of Medicinal Chemistry · 2007 · 51 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Blood Microsampling Using Capillaries for Drug-Exposure Determination in Early Preclinical Studies: A Beneficial Strategy to Reduce Blood Sample Volumes

Lieve Dillen, Tine Loomans, Guy Van de Perre et al. · Bioanalysis · 2014 · 35 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical Data

An Van den Bergh, Vikash Sinha, Ron Gilissen et al. · Clinical Pharmacokinetics · 2011 · 33 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Subchronic memantine induced concurrent functional disconnectivity and altered ultra-structural tissue integrity in the rodent brain: revealed by multimodal MRI

S. Sekar, Elisabeth Jonckers, Marleen Verhoye et al. · Psychopharmacology · 2013 · 21 citations · Full text

Medicine, Neurobiology, Neuroscience +17